2-methylbenzene-1,4-diamine,dihydrochloride | CAS:615-45-2

We serve 2-methylbenzene-1,4-diamine,dihydrochloride CAS:615-45-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-methylbenzene-1,4-diamine,dihydrochloride

Chemical Name:2-methylbenzene-1,4-diamine,dihydrochloride
CAS.NO:615-45-2
Synonyms:1,4-Benzenediamine,2-methyl-,dihydrochloride
Toluene-2,5-diamine,dihydrochloride
 2-Methyl-p-phenylendiamin,Dihydrochlorid
2,5-Diaminotoluene dihydrochloride
2-METHYL-1,4-BENZENEDIAMINE 
Molecular Formula:C7H12Cl2N2
Molecular Weight:195.09000
 
Physical and Chemical Properties:
Melting point:34-36oC;
Boiling point:170-173oC;
Flash point:230oF;
 
Specification:
Appearance:Light violet crystal powder
Purity(HPLC):≥98.0%
Ash:≤1.0%
Loss on drying:≤1.0%
Fe content:≤20ppm
Heavy metal:≤2ppm
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Hair dyes intermediate



Contact us for information like 2-methylbenzene-1,4-diamine,dihydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-METHYL-1,4-BENZENEDIAMINE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Toluene-2,5-diamine,dihydrochloride Use and application,Toluene-2,5-diamine,dihydrochloride technical grade,usp/ep/jp grade.


Related News: “We believe the iLet Bionics Pancreas System represents a true breakthrough therapy for the management of glycemia, particularly in type 1 diabetes,” said Ed Damiano, President and CEO of Beta Bionics. “We are partuclarly excited by the possibility that the iLet may be able to provide safer and more effective therapy in far more people than current therapies due to its simplicity of use.”1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethanone manufacturer “We believe the iLet Bionics Pancreas System represents a true breakthrough therapy for the management of glycemia, particularly in type 1 diabetes,” said Ed Damiano, President and CEO of Beta Bionics. “We are partuclarly excited by the possibility that the iLet may be able to provide safer and more effective therapy in far more people than current therapies due to its simplicity of use.”Cordycepin supplier At the same time, through years of imitation and advanced technology learning, more and more domestic companies have participated in the field of highly original and characteristic APIs.methyl 2-isocyanatosulfonylbenzoate vendor At the same time, through years of imitation and advanced technology learning, more and more domestic companies have participated in the field of highly original and characteristic APIs.API (Active Pharmaceutical Ingredient) means the active ingredient which is contained in medicine.